Meet the UCL TRO and UCLB at Advanced Therapies, ExCeL London

Advanced Therapies 2026 (public event)
17-18 March 2026, ExCel London

The Advanced Therapies Congress is Europe’s largest cell and gene therapy conference and exhibition.

The event is for the leaders of the world’s ATMP developers and their most senior executives in charge of the latest tech and strategies that are driving the industry forward. 

The UCL Translational Research Office (TRO) and UCL Business (UCLB) are delighted to partner with the event organisers to host our booth at this public conference. Visit us to learn more about UCL's ATMP developments and discuss collaboration opportunities.

About Advanced Therapies Congress

The Advanced Therapies Congress is Europe's largest commercial cell and gene therapy conference and exhibition. The event is for the leaders of pioneering ATMP companies and their most senior executives in charge of the latest tech and strategies that are driving the industry forward.

The conferences brings together a community of 3,300 global executives at ExCeL London, to be inspired by 300 speakers and 75 start-ups over 2 incredible days. The Advanced Therapies Congress features speakers from across the entire value chain of cell and gene therapy development; forward-thinking pharma, biotech and start- up companies, researchers, clinicians, academics, HTAs, payers and regulators.

Visit the official website.